Clinical trials
Phase 2/3 trials in Sweden with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anders Widmark | 1 |
| Asbjørn Mohr Drewes | 1 |
| Gilead Sciences | 1 |
| Jesper Ekelund | 1 |
| Karolinska Institutet | 1 |
| Knut Haadem | 1 |
| Linkoeping University | 1 |
| St. Erik Eye Hospital | 1 |
| Stockholm South General Hospital | 1 |
| Turku University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 1 |
| Arthritis, Rheumatoid | 1 |
| Birth Injuries | 1 |
| Burkitt Lymphoma | 1 |
| Choroidal Neovascularization | 1 |
| Femoral Neck Fractures | 1 |
| Leiomyoma | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lymphoma | 1 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.